ASP3082, a First-in-class novel KRAS G12D degrader, exhibits remarkable anti-tumor activity in KRAS G12D mutated cancer models
Takeyuki Nagashima, K. Inamura, Y. Nishizono, A. Suzuki, H. Tanaka, T. Yoshinari, Y. Yamanaka
Topics & Concepts
KRASCancer researchPancreatic cancerCancerCancer cellColorectal cancerCarcinogenesisBiologyMedicineInternal medicineProtein Kinase Regulation and GTPase SignalingColorectal Cancer Treatments and StudiesCancer Treatment and Pharmacology